Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-24 @ 3:22 PM
NCT ID:
NCT02854592
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* ischemic stroke diagnosed by CT or MRI
* first stroke onset or past stroke without obvious neurological deficit (mRS≤1)
* Time from onset to treatment: ≤ 4.5 hours
* Treatment with intravenous rtPA or urokinase
* Signed informed consent by patient self or legally authorized representatives
Exclusion Criteria:
* History of subarachnoid hemorrhage, intracranial hemorrhage and hemorrhagic cerebral infarction
* Obvious head injuries or strokes within 3 months
* Intracranial tumor, arteriovenous malformation or aneurysm
* Intracranial or spinal cord surgery within 3 months
* Gastrointestinal or urinary tract hemorrhage within the previous 21 days
* Blood glucose \< 50 mg/dl (2.7mmol/L)
* Heparin therapy or oral anticoagulation therapy within 48 hours
* Oral warfarin is being taken and INR\>1.6
* Severe systemic disease which is expected to survive less than 3 months
* Major surgery within 1 month
* Uncontrolled hypertension (\>180/100 mmHg)
* Platelet count \< 10×109／L
* Patients who have been involved in other clinical trials within 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02854592
Study Brief:
Protocol Section:
NCT02854592